In line with the results from our cohort, out of all PET-based parameters, whole body tumor SUVmean was the strongest predictor of response, and prognosticator for PFS and OS in patients undergoing [177Lu]Lu-PSMA radioligand therapy in prospective VISION study[32]. Here, FOLH1 is linked to neoplasm.